We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter describes how independent and supplementary prescribing can be used by non-medical prescribers in the treatment management of patients with dermatological conditions. Valuable insights are provided into the burden of skin conditions in healthcare today. Skin assessment using a biopsychosocial approach is addressed and discussion on how skin assessment influences prescribing decisions for topical and systemic treatments in primary care and the community. Three main principles of management are presented using atopic eczema, psoriasis and acne as examples, with a key focus on prescribing considerations. Remote prescribing is also discussed highlighting the 10 principles of safe and effective prescribing practice when traditional face-to-face consultations are not available. This chapter aims to optimise the decision-making skills of the non-medical practitioners involved in prescribing for common skin conditions
By
Deborah Lynn, UCLA Neuropsychiatric Institute, Los Angeles, California, USA,
Bryan H. King, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
Edited by
Stan Kutcher, Dalhousie University, Nova Scotia
The psychopharmacology of aggression in humans typically focuses on physical, active, and direct aggressive acts. This chapter focuses aggression directed outside of one's self. J. M. Halperin's study implies that there is perhaps a developmental lesion that begins as aggression in children and may change as maturation resulting in variation in adult aggressive behavior. The medications most widely employed in the treatment of aggression, regardless of etiology, include major tranquilizers, antidepressants, and mood stabilizers. PRN medicines, or pro re nata, according to circumstances, constitute a common method for treating the acute aggression. The risk/benefit ratio of these medications must be considered as well as monitoring for side effects. Psychologic treatment modalities, including individual therapy, family treatment, and group therapy, either in the context of an outpatient or inpatient setting, should compliment pharmacotherapy. Behavioral therapy can be especially useful for the aggressive patient.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.